Stemline Therapeutics, Inc.
$58.9 M
Abeona Ttherapeutics, Inc. (fka PlasmaTech Biopharmaceuticals)
$14 M
Secondary/Follow-On
Joint Book-Runner
AtheroNova, Inc.
$3 M
Secondary/Follow-On
Sole Book-Runner
InterCloud Systems, Inc.
$44.3 M
M&A
DT Asia Investments Limited
$60 M
IPO
Co-Manager
Cellectar Biosciences, Inc.
$12.5 M
Secondary/Follow-On
Sole Book-Runner
American DG Energy, Inc.
$4 M
Secondary/Follow-On
Sole Book-Runner
Manhattan Bridge Capital, Inc.
$5 M
Secondary/Follow-On
Sole Book-Runner
Medical Transcription Billing, Corp.
$20.4 M
IPO
Joint Book-Runner
1347 Capital Corp.
$40 M
IPO
Co-Manager
Professional Diversity Network, Inc.
$40 M
M&A
GlobeImmune, Inc.
$15 M
IPO
Sole Book-Runner